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In the first instance highly hydrated collagen gels contract
to dense and compact gels when populated by fibroblasts.
We previously reported the involvement of fibronectin
(FN) in an early process of the collagen gel contraction,
utilizing a specific monoclonal antibody dubbed A3A5
(MoAb-A3A5) that inhibits the gel contraction. This
study was performed to further characterize the role of
the epitope for MoAb-A3A5 in the interaction between
fibroblasts and collagen fibrils. Although both cellular
FN (cFN) and plasma FN (pFN) were reactive with
MoAb-A3A5, the FN that actually participates in a process
of the gel contraction was shown to be cFN. The gel
contraction was significantly accelerated when fibroblasts
were pretreated with excess amounts of cFN and was
significantly inhibited when the collagen molecules were
pretreated with excess cFN. Such effects of the pretreat-
ments were not observed for pFN. The involvement of
Collagen molecules are extracellularly assembled intofibrils, fibers, and then bundles. At first, these fibrilsare randomly oriented. They are arranged into well-organized tissue-specific architectures during the processof collagen morphogenesis and maturation. This
arrangement proceeds in a cell-dependent manner (Birk and Trelstad,
1986). Collagen gel culture was first systematically studied by Ehrmann
and Gey (1956) who cultured various types of mammalian cells on
transparent three-dimensional lattices of hydrated collagen gels. Elsdale
and Bard (1972) characterized fibroblasts cultured within the gel,
considering that collagen gel culture produces conditions that are closer
to the in vivo environment than monolayer culture on plastics.
Bell et al (1979) first noticed that fibroblast-populated collagen gel,
which is originally highly hydrated, is drastically reduced in volume
(contraction), forming a compact and dense gel. This contraction is a
cell-dependent process, which apparently indicates that the contraction
is mediated by the cell membrane protein that interacts with collagen
fibrils. Actually, the involvement of integrin α2β1, a receptor for
collagens, in this process was shown by Schiro et al (1991). The
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cFN, but not pFN, in the interaction of fibroblasts with
collagen fibrils was additionally shown by the similar
inhibitory action of cFN, but not pFN, on the spreading
and elongation of fibroblasts on collagen fibrils. The
epitope for MoAb-A3A5 was strongly suggested to be a
new functional domain responsible for the interactions
between fibroblasts and native collagen molecules. This
was not the case for those with denatured one, because
fibroblasts on collagen fibrils were not stainable with
MoAb-A3A5, whereas the interactions on gelatin were
stainable. The lack of the reactivity of fibroblasts on
collagen fibrils toward MoAb-A3A5 was not a result of
the absence of FN on the cell membrane, but seemed to
be a steric hindrance to the access of the antibody.
Key words: artificial dermis/cell to matrix binding/extracellular
matrix proteins. Journal of Investigative Dermatology Sympo-
sium Proceedings 4:190–195, 1999
involvement of β1 integrin matrix receptors was also suggested by
Tomasek and Akiyama (1992).
We produced a unique monoclonal antibody dubbed A3A5 (MoAb-
A3A5) that inhibits the contraction of human fibroblast-incorporated
collagen gel (Asaga et al, 1991). MoAb-A3A5 was revealed to be an
antibody against human fibronectin (FN).
Both plasma and cellular FN (pFN and cFN, respectively) are
reactive with the antibody. The epitope on the FN molecule was
restricted to a 122 amino acid-containing peptide covering the
sequences of the entire type III4, and the amino-terminal one-third of
type III5 by western blotting for both pepsin-digests of FN and
recombinant peptides expressed by E. coli transformed by cDNA coding
for its various fragments (Obara and Yoshizato, 1997). This identified
epitope region is unique in that no biologic functions have been
assigned for this specific segment.
The objectives of our study were to determine the role of cFN in
the collagen gel contraction and to characterize the epitope for MoAb-
A3A5. We sought to examine the effects of pFN and cFN on the
process of gel contraction. We previously proposed that pFN is not
required for gel contraction to occur, because the gel normally contracts
when pFN is absent (Asaga et al, 1991). This study obtained direct
evidence to support this proposal. Furthermore, we strongly suggested
specific interaction of the epitope for MoAb-A3A5 with collagen
fibrils, but not with gelatin, because the cells on collagen fibrils, but
not on gelatin, were not stainable with MoAb-A3A5, in spite of the
fact that these cells on both collagen fibrils and gelatin were stainable
with antifibronectin antibodies. Our results suggested that this epitope
on the cell membrane was in a sterically specific configuration when
fibroblasts were attached to collagen fibrils.
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MATERIALS AND METHODS
Materials Chemicals and materials used in this study were obtained from the
following sources: MoAb-A3A5 was prepared by Asaga et al (1991). Dulbecco’s
modified Eagle’s medium (DMEM) was from GIBCO (Grand Island, NY) or
Kyokutou Pharmaceutical (Tokyo, Japan); fetal bovine serum (FBS) was
from GIBCO; ethylenediamine-tetraacetic acid and N-(2-hydroxymethy-1)-
piperazine-N9-2-ethanesulfonic acid (HEPES) was from Dojin Chemical Insti-
tute (Kumamoto, Japan); streptomycin sulfate and penicillin G were from
Meijiseika (Tokyo, Japan); tris (hydroxymethyl) aminomethane (Tris) and trypsin
were from Sigma (St. Louis, MO); Vectastain ABC kits were from Vector
Laboratories (Burlingam, CA); human pFN was from Hoechst Japan (Tokyo,
Japan); human cFN was from Fibrogenex (Morton Grove, IL); tissue culture
dishes were from Becton Dickinson Labware (Oxnard, CA); Millipore filters
and nitrocellulose membranes were from Millipore Japan (Tokyo, Japan); and
all other chemicals were of reagent grade and were purchased from Wako Pure
Chemical Industries (Osaka, Japan) or Nacalai Tesque (Kyoto, Japan).
Cell culture Human skin fibroblasts were obtained from explant cultures of
pieces of normal skin, obtained from a patient with consent as described
previously (Yoshizato et al, 1980) and used in this study. The fibroblasts were
maintained in DMEM medium containing 10% FBS, 10 mM NaHCO3, 20 mM
HEPES, 100 IU penicillin G per ml, and 100 µg streptomycin sulfate per ml,
in an incubator with a humidified atmosphere of 95% air and 5% CO2 at 37°C,
subcultured at a 1:1 split by being treated with 0.1% trypsin and 1 mM EDTA
dissolved in Ca-,Mg-free Hanks’ solution, and used for the study within 20
population-doubling times.
Deprivation of membrane-bound FN from fibroblasts was performed by
applying the method to purify FN from tissues that was originally reported by
Yamada et al (1977). Fibroblasts were detached from dishes by treatment with
trypsin and EDTA, collected by centrifugation, and incubated in suspension in
10% FBS-DMEM containing 1 M urea at 37°C for 1 h, and finally washed
with PBS. The viability of the cells after this operation was checked by the
trypan blue exclusion test and was more than 95%. Removal of at least some
FN from the cells was confirmed by western dot blots for the urea extract with
antihuman FN antibodies. The urea-treated fibroblasts were used for the gel
culture as described below for normal fibroblasts.
Collagen gel culture Cultivation of fibroblasts in collagen gels was performed
as previously described (Yoshizato et al, 1985b; Asaga et al, 1991; Obara and
Yoshizato, 1997), which was a slight modification of the method reported by
Elsdale and Bard (1972). Usually, 2 3 105 cells were suspended in 1 ml of
chilled 10% FBS-DMEM medium containing 0.1% collagen at 4°C, pH being
adjusted to 7.4 with 1N NaOH. Aliquots (0.2 ml and 1 ml) of the sol-like
medium were poured into bacteriologic dishes (6.1 mm and 25 mm diameter,
respectively). The dishes were transferred to an incubator kept at 37°C. The
cell-containing sols were gelated within 10 min. As a measure of gel contraction,
the diameter of gels was determined at appropriate time points of culture. The
studies shown in Fig 1–3 were performed to examine the effects of cFN and
pFN on collagen gel contraction. Identical experiments were performed three
times and similar results were reproducibly obtained for each of them. One of
the three experiments is shown in this study.
Electrophoresis and immunoblotting Polyacrylamide gel electrophoresis
in the presence of sodium dodecyl acetate (SDS-PAGE) was performed according
to Laemmli (1970). Samples were dissolved in sample buffer consisting of 10%
SDS, 5% 2-mercapto-ethanol, 62.5 mM Tris-HCl, pH 6.8, and boiled for
5 min, and applied to electrophoretic polyacrylamide gels of 3% for concentration
and 7%–15% for separation. After electrophoresis, the gels were stained with
Coomassie brilliant blue R-250 or electrically transferred to nitrocellulose
membranes by the method of Towbin et al (1979).
Quantitation of the extent of cell spreading and elongation on collagen
fibrils Tissue culture dishes were coated with collagen fibrils at a density of
100 µg per cm2 as described previously (Yoshizato et al, 1984, 1985a). Plain or
coated dishes were treated with pFN or cFN at a concentration of 140 µg per
cm2. Fibroblasts were inoculated in either of these dishes at a density of 2 3 104
cells per cm2 and cultured in the medium containing 0.7 mg per ml of either
pFN or cFN. The extent of cell spread was determined at 24 h of culture.
Cells were photographed through a phase contrast microscope. An enlarged
image of each of the cells on prints obtained for either untreated, pFN-, or
cFN-treated dishes was cut off with a pair of scissors and weighed. Knowing
that the weight of unit area was uniform in every part of the print, the area of
a cell was calculated from its measured weight. The area of 100 cells was
determined in each series of experiments. The extent of cell elongation was
determined by measuring the length of the long axis of elongated cells. Cells
were photographed and their enlarged images were obtained on prints as above.
Figure 1. Acceleration of gel contraction by cFN-treated fibroblasts.
Fibroblasts were preincubated with either 40 µg cFN per ml (n), 40 µg pFN
per ml (u), or vehicle solution (DMEM) (s) for 1 h at 37°C, washed with
PBS, and suspended at 2 3 105 cells per ml in DMEM containing 0.1%
collagen on ice. Two hundred microliters of the suspension was delivered into
6.1 mm diameter holes of 96 well plates. FBS was not included in the medium
of gel culture. The collagen gel culture was performed by placing the plates in
a 37°C incubator. The extent of contraction of gels was expressed as a diameter
of gels. Each point represents a single determination. As a positive control, gel
culture in the presence of 10% FBS was also performed and is indicated by
closed circles. The cells of the positive control were not preincubated with
FN. Each point represents a single determination.
The length of the long axis of 100 elongated cells was measured in each series
of experiments.
Immunocytochemistry FN was localized on fibroblasts by immunocyto-
chemical staining (McDonald, 1988). Fibroblasts were cultured at 2 3 105 cells
per well in 300 µl of medium for 3 d in 35 mm culture dishes precoated with
either gelatin or collagen fibrils as above, washed several times with PBS,
blocked with 2% bovine serum albumin in PBS at room temperature for
30 min, incubated with 1000-fold diluted polyclonal antihuman fibronectin
antibodies or 2-fold diluted hybridoma supernatants of MoAb-A3A5, and
washed extensively with PBS. Bound antibodies were visualized with Vecterstain
ABC kits using 3,39-diaminobenzidine (Graham and Karnovsky, 1966) as
the substrate.
RESULTS
Enhancement of collagen gel contraction by treating fibroblasts
with cFN, but not with pFN Our previous study (Asaga et al,
1991) showed that cFN, but not pFN, is required for the fibroblast-
mediated collagen gel contraction. This is because, first, MoAb-A3A5,
a monoclonal antibody against cFN and pFN of human origin, inhibits
the collagen gel contraction, and, second, human fibroblasts that have
been treated with excess human pFN show the same ability of gel
contraction as untreated control cells. To obtain direct evidence for
the role of cFN, we examined its effect on the gel contraction.
Fibroblasts were pretreated with 40 µg per ml of either cFN or pFN,
then incorporated into collagen gels. The gel contraction experiment
was performed in the absence of FBS, which is known to accelerate
the contraction (Steinberg et al, 1980). In the presence of FBS, gels
began to contract at 1 h of incubation and progressively decreased in
volume thereafter (Fig 1). The absence of FBS retarded and markedly
lessened the contraction. The fibroblasts pretreated with pFN showed
a contractile capacity similar to nontreated cells as was previously
shown (Asaga et al, 1991). In contrast, the cFN-pretreated fibroblasts
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Figure 2. Recovery of gel contraction ability of urea-treated fibroblasts
by treatment with cFN, but not with pFN. Fibroblasts were treated with
1 M urea at 37°C for 1 h and washed thoroughly with PBS, preincubated with
either cFN (n), pFN (u), or vehicle (DMEM) (s) as in Fig 1, then suspended
in DMEM containing 0.1% collagen. Collagen gel culture was performed as in
Fig 1. As a positive control, the gel culture of the urea-treated cells was also
performed in the presence of 10% FBS and is shown by closed circles. The
cells of the positive control were not preincubated with FN. Each point
represents a single determination.
showed a significantly stronger contractile ability than non-, or pFN-
treated cells, although this was still less than that manifested in the
presence of FBS.
As shown in Fig 1, fibroblasts retained some contractile ability even
in the absence of FBS. This could be because fibroblasts retain cFN
on their plasma membrane, continue to synthesize cFN, and additionally
deposit it on the membrane, although their activity of protein synthesis
is much depressed in the absence of FBS. To remove the membrane-
bound FN (cFN), fibroblasts were treated with urea and used for
experiments on gel contraction (Fig 2). The urea treatment greatly
decreased the gel contractile ability of fibroblasts and even the presence
of FBS could not restore the ability to that of normal fibroblasts. The
preincubation of the urea-treated cells with pFN did not improve their
contractile ability. On the other hand, the pretreatment with cFN
significantly improved it, although their ability was still less than that
in the presence of FBS. As expected, the ratio of the extent of the gel
contraction-inducing ability of cFN-treated cells to that of pFN-treated
ones was much higher in the FN-deprived cells than in normal
fibroblasts. These studies clearly indicated that cFN, but not pFN,
participates and plays some role(s) in an initial step of the fibroblast-
mediated collagen gel contraction, likely through mediating the binding
of fibroblasts to collagen fibrils. This implies that there is a functional
difference between cFN and pFN, at least as far as collagen gel
contraction is concerned.
Inhibition of gel contraction by treating collagen fibrils with
cFN, but not with pFN To obtain additional evidence that cFN
is actually involved in the collagen gel contraction, the gel culture was
performed using collagen that had been preincubated with either cFN
or pFN before introducing fibroblasts, anticipating that the contraction
of the cFN-preincubated collagen gel would be inhibited because the
hypothetical cFN-binding site of collagen fibrils was preoccupied by
cFN and cFN in the cell membrane that cannot bind themselves to
collagen fibrils. In this situation, the chance for fibroblasts to interact
Figure 3. Inhibition of fibroblast-mediated gel contraction by
pretreating the cells with cFN. Sol-like media were prepared by adding into
DMEM FBS at 10%, collagen at 0.1%, and either cFN (m) or pFN (j) at
100 µg per ml, or vehicle (DMEM) (d), and were preincubated for 1 h at
4°C. Fibroblasts were incorporated into these sol media and the gel culture was
performed as in Fig 1. Each point represents a single determination.
with collagen fibrils might be decreased to some extent. This anticipa-
tion was shown to be the case (Fig 3). There were no differences in
contraction between the normal and the pFN-preincubated gels,
whereas significant inhibition of the contraction was seen in the cFN-
preincubated gels as compared with the other two gels.
Inhibition of cell spreading and elongation of fibroblasts on
collagen fibrils by treating the fibrils with cFN, but not with
pFN To test the possibility that cFN, but not pFN, can mediate the
binding between fibroblasts and collagen fibrils, we investigated and
compared the effects of pretreatment of collagen fibrils with both FNs
on the spreading of fibroblasts on the fibrils. Culture dishes were
coated with collagen fibrils, then treated with either vehicle solution
(PBS), or PBS containing either pFN or cFN. Fibroblasts were cultured
for 12 h in these dishes and their figures were observed through a
phase contrast microscope (Fig 4). The cell spread on cFN-treated
collagen fibrils was clearly inhibited compared with that on the other
two fibrils. The cell spreading was quantitated by measuring the area
of fibroblasts: 2.1 6 0.3 3 10–6 mm2 per cell for control dishes (the
mean 6 SD obtained from measuring 100 cells), 2.060.2 for pFN
dishes, and 1.560.2 for cFN dishes. The spreading on collagen fibrils
was clearly decreased by pretreating the fibrils with cFN, suggesting
the involvement of cFN in the cell spreading on collagen fibrils.
As another measure of cell spreading, the length of the long axis of
elongated cells was determined at 4, 12, and 18 h of culture (Fig 5).
The measured length was shown as histograms of size distributions.
There were no differences in the pattern of the histograms among the
three at 4 h when the elongation was in its initial phase. A significant
delay of the elongation was noticed at 12 h for the cFN-treated dishes,
whereas the cells in pFN-treated dishes spread well to an extent similar
to those in control dishes. The inhibitory effect of cFN was not seen
any more at 18 h. Taking these results together, we concluded that
cFN competitively inhibited an initial step of the cell spreading on
collagen fibrils taking place around 12 h after the cell attachment,
suggesting its role in mediating the binding between fibroblasts and
collagen fibrils. pFN did not play any such role in this process.
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Figure 4. Inhibition of spreading of
fibroblasts on cFN-treated collagen
fibrils. Tissue culture dishes were coated with
collagen fibrils and treated with either vehicle
(PBS) (a), cFN (b), or pFN (c) as described in
the text. Fibroblasts were cultured in these
dishes for 12 h and were photographed
through a phase contrast microscope. Scale
bar: 50 µm.
Figure 5. Inhibition of cell elongation on
cFN-treated collagen fibrils. Tissue culture
dishes were coated with collagen fibrils and
preincubated with either vehicle (PBS) (a),
cFN (b), or pFN(c) as described in the text.
Fibroblasts were cultured on these dishes and
the extent of their elongation was determined
at 4, 12, and 18 h of culture by measuring
the length of the long axis of elongated cells.
Each column represents the incidence (%) of
cells whose average length of the long axis is
within the range indicated on the abscissa. A
total of 100 cells were measured at each time
point in each experiment. Vertical lines are
SD of the means.
Immunocytochemistry of fibroblasts on collagen fibrils by
MoAb-A3A5 Another unique property of cFN in mediating the
binding of fibroblasts to collagen fibrils was revealed by MoAb-A3A5,
which appeared to be related to structural changes of cFN when
complexed with collagen fibrils. Fibroblasts were cultured in a mono-
layer on either plain plastic, or plastic coated with either gelatin or
collagen fibrils. Immunohistochemistry with MoAb-A3A5 showed that
human fibroblasts on gelatin as well as on plain plastic were stainable
by this antibody, whereas those on collagen fibrils were not (Fig 6d,
e, f). The possibility that the fibroblasts on collagen fibrils do not
deposit cFN molecules was ruled out, because polyclonal antibodies
against FN stained fibroblasts on both substrates (Fig 6g, h, i). The
distinction by MoAb-A3A5 of fibroblasts on collagen fibrils from those
on gelatin strongly suggested the involvement of cFN in the interaction
between fibroblasts and collagen fibrils, and the importance of the
steric configuration of cFN aggregates on the cell membrane for the
access of the antibody. It was also suggested that the changes in steric
configuration of cFN molecules were directly associated with the
binding between cFN and collagen molecules. The comparison of
microscopic figures of fibroblasts on these three substrates demonstrated
that the morphology of cells on collagen fibrils was unique as compared
with that on the other two substrates: they were thinner and had
abundant cell protrusions with many thin filamentous structures
(Fig 6a, b, c).
DISCUSSION
MoAb-A3A5 was shown to be a useful probe to study the mechanism
of fibroblast-mediated collagen gel contraction because this MoAb
uniquely inhibits collagen gel contraction (Asaga et al, 1991). Although
MoAb-A3A5 recognizes both cFN and pFN, the FN that is responsible
for the antibody-induced inhibition of the gel contraction was con-
cluded to be cFN, not pFN, by this study. We presented two pieces
of evidence for this conclusion. First, the contraction-inducing ability
of fibroblasts was increased by pretreating the cells with cFN, but not
with pFN. This increase was more evident when urea-treated cells
were used in place of normal cells. Second, this ability was inhibited
by pretreating the collagen gel with cFN, but again not with pFN.
This study also demonstrated that one of the MoAb-A3A5-sensitive
processes leading to the gel contraction was the spreading and the
elongation of fibroblasts on the collagen fibrils. This was shown by
the conventional monolayer culture of fibroblasts. When fibroblasts
meet collagen fibrils, they interact with the fibrils first by attaching to
them, then by spreading on them by protruding filopodia, and finally
by elongating themselves on the substratum (Tomasek and Hay, 1984).
We showed that MoAb-A3A5 inhibited both the spreading and the
elongation. These two early interactions between fibroblasts and
collagen fibrils require cFN, but not pFN, because we showed in this
study that these interactions were clearly delayed when collagen
molecules had been pretreated with cFN.
The results presented in this report propose the presence of at least
two different mechanisms for FN-mediated interactions between
fibroblasts and collagen molecules. There are two different forms of
molecules of FN and collagen: cFN and pFN in FN, and native and
denatured collagens in collagen. This study shows that fibroblasts
contain a unique mechanism for interacting with collagen fibrils, which
differs from the mechanism for interacting with denatured collagen
molecules (gelatin). The former mechanism was revealed by utilizing
MoAb-A3A5. Collectively considering data presented here and else-
where (Asaga et al, 1991), we strongly suggest that interactions between
fibroblasts and denatured collagen can be mediated by pFN, and those
between fibroblasts and native collagen (collagen fibrils) can be mediated
by cFN, but not by pFN. Identification of molecules involved in the
two mechanisms, the pFN-dependent and cFN-dependent interactions
between fibroblasts and collagen molecules, remains an intriguing
target for further investigations. It is most likely that pFN-dependent
interactions are mediated through the gelatin-binding domain of a FN
molecule (McDonald and Kelley, 1980) on the one hand and the cell-
binding domain on the other hand (Pierchbacher and Ruoslahti, 1984).
The interaction between cFN and collagen fibrils appears to be
different from that between pFN and gelatin. The characteristics of
fibroblasts on collagen fibrils differ from those on gelatin. The DNA
synthesis of fibroblasts on collagen fibrils is much depressed as compared
with that on gelatin (Yoshizato et al, 1985a). The fibroblasts on collagen
fibrils take on a typical spindle-like appearance and protrude abundant
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Figure 6. Immunostaining of fibronectin
matrices produced by fibroblasts.
Fibroblasts were seeded onto dishes uncoated
(a, d, g) or coated with either gelatin (b, e, h)
or collagen fibrils (c, f, i), which had been
prepared as described in the text. The cells
were cultured in DMEM-10% FBS for 3 d,
washed with PBS, stained with either MoAb-
A3A5 (d, e, f) or polyclonal antihuman FN
antibodies (g, h, i), and photographed.
Photomicrographs of (a), (b), and (c) represent
the morphology of cells cultured
on the different substrates before the
immunostaining. Scale bar: 50 µm.
cell processes, which is quite different from those on gelatin (Yoshizato
et al, 1984, 1985a; as shown also in Fig 6c of this study). More
interestingly, MoAb-A3A5 stains fibroblasts on either gelatin (Fig 6e)
or plastic (Fig 6a and also shown by Asaga et al, 1991), but not those
on collagen fibrils (Fig 6f and also shown by Asaga et al, 1991). This
lack of stainability for MoAb-A3A5 was not due to a lack of cFN
molecules on the plasma membrane of fibroblasts on collagen fibrils,
because its presence was shown by immunocytochemistry with poly-
clonal antihuman FN antibodies (Fig 6i) or by western blots with the
antibodies for fibroblasts cultured on collagen fibrils (Asaga et al, 1991).
The reason for this substrate-dependent recognition of FN by MoAb-
A3A5 remains unknown. We speculate that the steric configuration of
cFN on the surface membrane of fibroblasts might be unique on
collagen fibrils, which induces a specific conformation of peptides in
the region containing the MoAb-A3A5 epitope that inhibits the access
of MoAb-A3A5 to its epitope.
Our previous study restricted the epitope on a FN molecule
responsible for MoAb-A3A5 to the III4 through the N-terminal
one-third region of III5 containing 122 amino acid residues (Obara
and Yoshizato, 1997). This specific region has not been assigned
any known biologic function such as the fibrin-binding domain for
type I1 to I5 and type I10 to I12, heparin-binding domain for type
I1 to I5 and III12 to III14, gelatin-binding domain for type I6 to I9
and II1 to II2, and cell-binding domain for III8 to III10 (Yamada,
1989, 1991; Hynes, 1990). We suppose that this new region
consisting of 122 amino acid residues contains a functional domain
responsible for the interactions of fibroblasts with native collagen
molecules that exist as forms of either fibrils, fibers, or bundles
depending on the physiologic and pathologic conditions in vivo.
Further characterization of the epitope is being undertaken in our
laboratory, focusing on the question of whether this epitope can
directly bind itself to collagen fibrils.
It should be emphasized that the proposals concerning the new
functional domain of the FN molecule and distinctive recognition
by fibroblasts of native and denatured collagen were made by using
a three-dimensional collagen gel culture. This culture has been
generally accepted as an in vitro model that mimics in vivo conditions
more closely than the conventional monolayer culture. Thus, the
new proposals described in this study should contribute to obtaining
an insight into the mechanisms of cell to collagen interactions that
take place in vivo. It is tempting to speculate that fibroblasts interact
with denatured collagen molecules through the well-characterized
collagen binding domain of cFN (Hynes, 1990), and that the cells
interact with collagen fibrils through the new domain revealed by
MoAb-A3A5.
Integrins, a family of receptors of a variety of ECM, are present on
the surface of fibroblasts (Yamada, 1989) and are considered to function
in the process of the collagen gel contraction. In fact, β1 integrin
subunits that function as collagen-receptors were reported to participate
in gel contraction (Schiro et al, 1991; Tomasek and Akiyama, 1992);
however, α5β1 integrins have been shown not to be involved in the
process (Tomasek and Akiyama, 1992), which is noteworthy in relation
to this study, because these integrins are fibronectin-specific receptors
(Yamada, 1989). We demonstrated some role(s) of cFN, but not pFN,
in the collagen gel contraction in this study and elsewhere (Asaga et al,
1991). It is likely that the study cited above examined the role of the
interaction between pFN and α5β1, but not between cFN and α5β1.
The mechanism of aggregate formation of cFN on the cell surface has
VOL. 4, NO. 2 SEPTEMBER 1999 BINDING OF COLLAGEN WITH FIBRONECTIN 195
been largely unknown (McDonald, 1988; Hynes, 1990). The elucida-
tion of this mechanism will help identify the membrane proteins
responsible for the cFN-mediated collagen gel contraction.
This study was supported in part by the Promotion of Fundamental Studies in Health
Science of the Organization for Pharmaceutical Safety and Research (OPSR).
REFERENCES
Asaga H, Kikuchi S, Yoshizato K: Collagen gel contraction by fibroblasts requires cellular
fibronectin but not plasma fibronectin. Exp Cell Res 193:167–174, 1991
Bell EB, Ivarsson B, Merril C: Production of a tissue-like structure by contraction of
collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc
Natl Acad Sci USA 76:1274–1278, 1979
Birk D, Trelstad RL: Extracellular components in tendon morphogenesis: collagen fibril,
bundle, and macroaggregate formation. J Cell Biol 103:231–240, 1986
Ehrmann RL, Gey GO: The growth of cells on a transparent gel of reconstituted rat-tail
collagen. J Natl Can Inst 16:1375–1402, 1956
Elsdale T, Bard J: Collagen substrata for studies on cell behavior. J Cell Biol 54:626–637, 1972
Graham RC, Karnovsky MJ: The early stages of absorption of injected horseradish
peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry
by a new technique. J Histochem Cytochem 14:291–298, 1966
Hynes RO: Fibronectins. New York: Springer-Verlag, 1990
Laemmli UK: Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature 227:680–685, 1970
McDonald JA: Extracellular matrix assembly. Ann Rev Cell Biol 4:183–207, 1988
McDonald JA, Kelley DG: Degradation of fibronectin by human leukocyte elastase.
Release of biological fragments. J Biol Chem 255:8848–8858, 1980
Obara M, Yoshizato K: A novel domain of fibronectin revealed by epitope mapping of a
monoclonal antibody which inhibits fibroblasts-mediated collagen gel contraction.
FEBS Lett 412:48–52, 1997
Pierchbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated
by small synthetic fragments of the molecules. Nature 309:30–33, 1984
Schiro JA, Chan BM, Roswit WT, et al: Integrin α2β1 (VLA-2) mediates reorganization
and contraction of collagen matrices by human cells. Cell 67:403–410, 1991
Steinberg BM, Smith K, Colozzo M, Pollack R: Establishment and transformation diminish
the ability of fibroblasts to contract a native collagen gel. J Cell Biol 87:304–308, 1980
Tomasek JJ, Akiyama SK: Fibroblast-mediated collagen gel contraction does not require
fibronectin α5β1 integrin interaction. Anat Rec 234:153–160, 1992
Tomasek JJ, Hay ED: Analysis of the role of microfilaments and microtubules in acquisition
of bipolarity and elongation of fibroblasts in hydrated collagen gels. J Cell Biol
99:536–549, 1984
Towbin H, Staehelin T, Gordon T: Electrophoretic transfer of proteins from polyacrylamide
gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci
USA 76:4350–4354, 1979
Yamada KM: Fibronectin domains and receptors. In: Morsher D (eds). Fibronectin New
York: Academic Press, 1989
Yamada KM: Adhesive recognition sequences. J Biol Chem 266:12809–12812, 1991
Yamada KM, Schlesinger DH, Kennedy DW, Pastan I: Characterization of a major
fibroblast cell surface glycoprotein. Biochemistry 16:5552–5559, 1977
Yoshizato K, Kikuyama S, Shioya N: Stimulation of glucose utilization and lactate
production in cultured human fibroblasts by thyroid hormone. Biochim Biophys Acta
627:23–29, 1980
Yoshizato K, Taira T, Shioya N: Collagen dependent growth suppression and changes in
the shape of human dermal fibroblasts. Ann Plas Surg 13:9–14, 1984
Yoshizato K, Taira T, Yamamoto N: Growth inhibition of human fibroblasts by reconstituted
collagen fibrils. Biomed Res 6:61–71, 1985a
Yoshizato K, Taira T, Yamamoto N, Sasaki K: Remodeling of collagen in an in vitro model
of connective tissue. Biomed Res 6:287–296, 1985b
